BioMarin Pharmaceutical - 48 Year Dividend History | BMRN

Historical dividend payout and yield for BioMarin Pharmaceutical (BMRN) since 1971. The current TTM dividend payout for BioMarin Pharmaceutical (BMRN) as of April 25, 2019 is $0.00. The current dividend yield for BioMarin Pharmaceutical as of April 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.249B $1.491B
BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment of mucopolysaccharidosis-I, or MPS-I. Patients were treated with BM101 as part of a pivotal clinical trial completed to determine the safety and efficacy of the drug in humans.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.824B 12.37
Gilead Sciences (GILD) United States $80.063B 10.19
Bio-Techne Corp (TECH) United States $7.211B 48.58